Overview
Peritoneal inclusion cyst, also known as benign cystic mesothelioma or benign multicystic peritoneal mesothelioma, is a rare condition characterized by the formation of thin-walled, fluid-filled cystic masses within the peritoneal cavity (the lining of the abdomen and pelvis). Despite the ICD-10 classification under malignant mesothelioma codes (C45.1), peritoneal inclusion cysts are generally considered benign or borderline neoplasms arising from the mesothelial cells that line the peritoneum. The condition predominantly affects women of reproductive age, often those with a history of prior abdominal or pelvic surgery, pelvic inflammatory disease, or endometriosis. The cysts typically develop in the pelvis and may surround or encase the ovaries and other pelvic structures. Key symptoms include chronic or recurrent pelvic or abdominal pain, abdominal distension, and the presence of a palpable abdominal or pelvic mass. Some patients may experience gastrointestinal symptoms such as bloating, nausea, or changes in bowel habits due to mass effect. The condition can be challenging to diagnose, as imaging findings may mimic ovarian cysts, lymphangiomas, or malignant peritoneal mesothelioma. Diagnosis is typically confirmed through histopathological examination showing benign mesothelial-lined cystic spaces. Treatment primarily involves surgical excision, which may range from laparoscopic drainage and cyst removal to more extensive debulking surgery depending on the size and extent of the cysts. However, recurrence rates are notably high, reported in up to 50% of cases, often necessitating repeated surgical interventions. Hormonal therapies, including gonadotropin-releasing hormone agonists and tamoxifen, have been explored as adjunctive treatments to reduce recurrence risk, though evidence remains limited. Sclerotherapy has also been attempted in some cases. Long-term follow-up is recommended due to the significant recurrence rate, though malignant transformation is exceedingly rare.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Peritoneal inclusion cyst.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Peritoneal inclusion cyst at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Peritoneal inclusion cyst.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Peritoneal inclusion cyst.
Community
No community posts yet. Be the first to share your experience with Peritoneal inclusion cyst.
Start the conversation →Latest news about Peritoneal inclusion cyst
No recent news articles for Peritoneal inclusion cyst.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Peritoneal inclusion cyst
What is Peritoneal inclusion cyst?
Peritoneal inclusion cyst, also known as benign cystic mesothelioma or benign multicystic peritoneal mesothelioma, is a rare condition characterized by the formation of thin-walled, fluid-filled cystic masses within the peritoneal cavity (the lining of the abdomen and pelvis). Despite the ICD-10 classification under malignant mesothelioma codes (C45.1), peritoneal inclusion cysts are generally considered benign or borderline neoplasms arising from the mesothelial cells that line the peritoneum. The condition predominantly affects women of reproductive age, often those with a history of prior a
How is Peritoneal inclusion cyst inherited?
Peritoneal inclusion cyst follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Peritoneal inclusion cyst typically begin?
Typical onset of Peritoneal inclusion cyst is adult. Age of onset can vary across affected individuals.